(Q34149992)

31 July 2017

Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America (English)

1 reference

lung small cell carcinoma

31 July 2017

0 references

1 reference

2

Boris Freidlin

1 reference

31 July 2017

1

Pasi A Jänne

1 reference

31 July 2017

Scott Saxman

3

1 reference

31 July 2017

David H Johnson

4

1 reference

31 July 2017

Robert B Livingston

5

1 reference

31 July 2017

Frances A Shepherd

6

1 reference

31 July 2017

Bruce E Johnson

7

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

31 July 2017

1 reference

31 July 2017

95

1 reference

31 July 2017

1528-1538

1 reference

31 July 2017

7

1 reference

A meta-analysis of thoracic radiotherapy for small-cell lung cancer

31 July 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Assessment of the Role of Surgery for Control of Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Long-term survival in small cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Increased survival with high-dose multifield radiotherapy and intensive chemotherapy in limited small cell carcinoma of the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Chemotherapy versus chemoimmunotherapy for small-cell undifferentiated carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Combination chemotherapy-radiotherapy with and without the methanol-extraction residue of Bacillus Calmette-Guerin (MER) in small cell carcinoma of the lung: a prospective randomized trial of the Piedmont Oncology Association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

A randomized trial to compare intravenous and oral etoposide in combination with cisplatin for the treatment of small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Prophylactic cranial irradiation in small cell carcinoma of the lung. A randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Combined modality treatment of regional small cell undifferentiated carcinoma of the lung: a cooperative study of the RTOG and ECOG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Combination chemotherapy, radiotherapy, and BCG immunotherapy in limited small-cell carcinoma of the lung: A Southwest Oncology group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Combined modality therapy with radiotherapy, chemotherapy, and immunotherapy in limited small-cell carcinoma of the lung: a Phase III cancer and Leukemia Group B Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Treatment of limited-stage small-cell lung cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Central Cancer Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Late consolidative radiation therapy in the treatment of limited-stage small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P-glycoprotein-mediated drug resistance in the first-line management of small-cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Proceedings: Small cell carcinoma of the lung: staging, paraneoplastic syndromes, treatment, and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Treatment of small cell lung cancer with VP-16, vincristine, doxorubicin (Adriamycin), cyclophosphamide (EVAC), and high-dose chest radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Cigarette smoking and changes in the histopathology of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

FDG-PET imaging for the staging and follow-up of small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Treatment of small-cell lung cancer on protocol: potential bias of results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Re: A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer Institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

A randomized combined modality trial in small cell carcinoma of the lung comparison of combination chemotherapy-radiation therapy versus cyclophosphamide-radiation therapy effects of maintenance chemotherapy and prophylactic whole brain irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Thoracic and elective brain irradiation with concomitant or delayed multiagent chemotherapy in the treatment of localized small cell carcinoma of the lung: a randomized prospective study by the Southeastern Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a So

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

VP-16-213 in combination chemotherapy with chest irradiation for small-cell lung cancer: a randomized trial of the Piedmont Oncology Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

A phase I-II study of sequential infusion VP-16 and cisplatin therapy in advanced lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Positron emission tomography in the staging of small-cell lung cancer : a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Response rates, survival, and chemotherapy trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

Chemotherapy plus RA233 in the treatment of oat cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10841

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.10841

1 reference

31 July 2017

1 reference